Deriving early single-rosette brain organoids from human pluripotent stem cells
Stem Cell Reports · 2023-12 · 18 (12) · 2498-2514
DOI: 10.1016/j.stemcr.2023.10.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2023-12. Verfasst von Andrew M Tidball und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Pluripotent Stem Cells. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Brain organoid methods are complicated by multiple rosette structures and morphological variability. We have developed a human brain organoid technique that generates self-organizing, single-rosette cortical organoids (SOSR-COs) with reproducible size and structure at early timepoints. Rather than patterning a 3-dimensional embryoid body, we initiate brain organoid formation from a 2-dimensional monolayer of human pluripotent stem cells patterned with small molecules into neuroepithelium and differentiated to cells of the developing dorsal cerebral cortex. This approach recapitulates the 2D to 3D developmental transition from neural plate to neural tube. Most monolayer fragments form spheres with a single central lumen. Over time, the SOSR-COs develop appropriate progenitor and cortical laminar cell types as shown by immunocytochemistry and single-cell RNA sequencing. At early time points, this method demonstrates robust structural phenotypes after chemical teratogen exposure or when modeling a genetic neurodevelopmental disorder, and should prove useful for studies of human brain development and disease modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA.
- Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA.
- Department of Neurology, Washington University School of Medicine, Saint Louis, MO, USA.
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA; Michigan Neuroscience Institute, University of Michigan Medical School, Ann Arbor, MI, USA.
- Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI, USA.
Förderung
- NINDS NIH HHS
- NICHD NIH HHS
- National Institute of Child Health and Human Development
- University of Michigan
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Tidball, A. M., Niu, W., Ma, Q., Takla, T. N., Walker, J. C., Margolis, J. L., Mojica-Perez, S. P., Sudyk, R., Deng, L., Moore, S. J., Chopra, R., Shakkottai, V. G., Murphy, G. G., Yuan, Y., Isom, L. L., Li, J. Z., & Parent, J. M. (2023). Deriving early single-rosette brain organoids from human pluripotent stem cells. Stem Cell Reports, 18(12), 2498-2514. https://doi.org/10.1016/j.stemcr.2023.10.020
Vancouver
Tidball AM, Niu W, Ma Q, Takla TN, Walker JC, Margolis JL, et al. Deriving early single-rosette brain organoids from human pluripotent stem cells. Stem Cell Reports. 2023;18(12):2498-2514. doi:10.1016/j.stemcr.2023.10.020
BibTeX
@article{Tidball2023,
author = {Tidball, Andrew M and Niu, Wei and Ma, Qianyi and Takla, Taylor N and Walker, J Clayton and Margolis, Joshua L and Mojica-Perez, Sandra P and Sudyk, Roksolana and Deng, Lu and Moore, Shannon J and Chopra, Ravi and Shakkottai, Vikram G and Murphy, Geoffrey G and Yuan, Yukun and Isom, Lori L and Li, Jun Z and Parent, Jack M},
title = {Deriving early single-rosette brain organoids from human pluripotent stem cells},
journal = {Stem Cell Reports},
year = {2023},
volume = {18},
number = {12},
pages = {2498--2514},
doi = {10.1016/j.stemcr.2023.10.020}
}
EUVIMED